{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:21:22Z","timestamp":1784247682806,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY025350"],"award-info":[{"award-number":["R01 EY025350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10 EY023939"],"award-info":[{"award-number":["U10 EY023939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1Y028088"],"award-info":[{"award-number":["UG1Y028088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ophtha.2019.11.001","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T11:27:46Z","timestamp":1573558066000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Trachoma: Time to Talk Eradication"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8216-0240","authenticated-orcid":false,"given":"Thomas M.","family":"Lietman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-399X","authenticated-orcid":false,"given":"Catherine E.","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-1457","authenticated-orcid":false,"given":"Jeremy D.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2019.11.001_bib1","series-title":"A\u00a0blinding scourge from the bronze age to the twenty-first century","author":"Trachoma","year":"2008"},{"issue":"1","key":"10.1016\/j.ophtha.2019.11.001_bib2","first-page":"115","article-title":"Global data on blindness","volume":"73","author":"Thylefors","year":"1995","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.ophtha.2019.11.001_bib3","series-title":"Report of the Third Meeting of the W.H.O. Alliance for the Global Elimination of Trachoma","year":"1999"},{"issue":"Suppl 2","key":"10.1016\/j.ophtha.2019.11.001_bib4","first-page":"22","article-title":"The principles of disease elimination and eradication","volume":"76","author":"Dowdle","year":"1998","journal-title":"Bull World Health Org"},{"issue":"45","key":"10.1016\/j.ophtha.2019.11.001_bib5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.15585\/mmwr.mm6745a3","article-title":"Progress toward global eradication of dracunculiasis\u2014January 2017\u2013June 2018","volume":"67","author":"Hopkins","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2019.11.001_bib6","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1093\/inthealth\/ihx039","article-title":"Progress toward elimination of onchocerciasis in the Americas","volume":"10","author":"Sauerbrey","year":"2018","journal-title":"Int Health"},{"issue":"38","key":"10.1016\/j.ophtha.2019.11.001_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.15585\/mmwr.mm6838a3","article-title":"Progress toward poliovirus containment implementation\u2014worldwide, 2018\u20132019","volume":"68","author":"Moffett","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.ophtha.2019.11.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002562","article-title":"Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts","volume":"7","author":"Keenan","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.ophtha.2019.11.001_bib9","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3201\/eid1011.040476","article-title":"Trachoma decline and widespread use of antimicrobial drugs","volume":"10","author":"Chidambaram","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"9064","key":"10.1016\/j.ophtha.2019.11.001_bib10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(97)01355-X","article-title":"Reduction of trachoma in a sub-Saharan village in absence of a disease control programme","volume":"349","author":"Dolin","year":"1997","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.ophtha.2019.11.001_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1076\/opep.8.2.145.4169","article-title":"Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi","volume":"8","author":"Hoechsmann","year":"2001","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.11.001_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/342298","article-title":"Disappearance of trachoma in western Nepal","volume":"35","author":"Jha","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ophtha.2019.11.001_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0b013e318074e01b","article-title":"The real challenge: can we discover why trachoma is disappearing before it\u2019s gone?","volume":"47","author":"House","year":"2007","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"10.1016\/j.ophtha.2019.11.001_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/clinids\/24.3.363","article-title":"A\u00a0comparison of oral azithromycin with topical oxytetracycline\/polymyxin for the treatment of trachoma in children","volume":"24","author":"Dawson","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"8869","key":"10.1016\/j.ophtha.2019.11.001_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0140-6736(93)91591-9","article-title":"Randomised controlled trial of single-dose azithromycin in treatment of trachoma","volume":"342","author":"Bailey","year":"1993","journal-title":"Lancet"},{"issue":"9179","key":"10.1016\/j.ophtha.2019.11.001_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(98)12387-5","article-title":"Azithromycin in control of trachoma","volume":"354","author":"Schachter","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ophtha.2019.11.001_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.295.10.1142","article-title":"Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma","volume":"295","author":"Chidambaram","year":"2006","journal-title":"JAMA"},{"issue":"9669","key":"10.1016\/j.ophtha.2019.11.001_bib18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(09)60323-8","article-title":"Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial","volume":"373","author":"House","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ophtha.2019.11.001_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/8451","article-title":"Global elimination of trachoma: how frequently should we administer mass chemotherapy?","volume":"5","author":"Lietman","year":"1999","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ophtha.2019.11.001_bib20","first-page":"477","article-title":"A\u00a0simple system for the assessment of trachoma and its complications","volume":"65","author":"Thylefors","year":"1987","journal-title":"Bull World Health Org"},{"issue":"4","key":"10.1016\/j.ophtha.2019.11.001_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archophthalmol.2011.46","article-title":"Slow resolution of clinically active trachoma following successful mass antibiotic treatments","volume":"129","author":"Keenan","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.11.001_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1167\/iovs.11-8493","article-title":"Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions","volume":"53","author":"Keenan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ophtha.2019.11.001_bib23","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/cid\/ciy377","article-title":"Ocular Chlamydia trachomatis infection under the Surgery, Antibiotics, Facial Cleanliness, and Environmental Improvement Strategy in Amhara, Ethiopia, 2011\u20132015","volume":"67","author":"Nash","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ophtha.2019.11.001_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-3156.2000.00603.x","article-title":"Review of the evidence base for the \u2018F\u2019 and \u2018E\u2019 components of the SAFE strategy\u00a0for trachoma control","volume":"5","author":"Emerson","year":"2000","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.ophtha.2019.11.001_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.inhe.2011.03.004","article-title":"Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial","volume":"3","author":"Stoller","year":"2011","journal-title":"Int Health"},{"issue":"9811","key":"10.1016\/j.ophtha.2019.11.001_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(11)61515-8","article-title":"Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial","volume":"379","author":"Gebre","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ophtha.2019.11.001_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.299.7.778","article-title":"Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma","volume":"299","author":"Melese","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2019.11.001_bib28","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ophtha.2009.04.041","article-title":"Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions","volume":"116","author":"Biebesheimer","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.11.001_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/526777","article-title":"Complete elimination is a difficult goal for trachoma programs in severely affected communities","volume":"46","author":"Gill","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ophtha.2019.11.001_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002633","article-title":"Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: a continuation study of randomly reassigned subclusters (TANA II)","volume":"15","author":"Keenan","year":"2018","journal-title":"PLoS Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019322171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019322171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:53:31Z","timestamp":1777492411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019322171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0161642019322171"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.001","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trachoma: Time to Talk Eradication","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}